Figure 2 | British Journal of Cancer

Figure 2

From: Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response

Figure 2

Plasma OPN expression in response to local treatment. For each figure: black lines represents patients with decreasing plasma OPN from baseline following treatment, whereas red lines represents patients with increasing plasma OPN from baseline following treatment. The median values pre and post treatment are indicted by the horizontal black bar. (A) Low-risk PCa treated with radical prostatectomy (n=18); (B) High-risk PCa treated with radical prostatectomy and pelvic lymph node dissection (n=39); (C) Intermediate risk PCa treated with radical prostatectomy±pelvic lymph node dissection (n=22); (D) Intermediate-risk PCa treated with IMRT 60 Gy in 20 daily fractions (n=12); (E) Intermediate-risk PCa treated with IMRT 78 Gy in 39 daily fractions (n=29); Only in the low risk group there was a significant response in OPN following surgery (P-value 0.005).

Back to article page